Join the Gamunex-C group to help and get support from people like you.
Gamunex-C News
Patients With Leukemia Have Higher Infection Risk During Immunoglobulin Replacement Therapy
THURSDAY, Aug. 7, 2025 – For patients with chronic lymphocytic leukemia (CLL), regular treatment with immunoglobulin replacement therapy (IgRT) is associated with an increased incidence of...
FDA Medwatch Alert: Voluntary Lot Withdrawals of Immune Globulin Intravenous (IGIV) and Immune Globulin Subcutaneous (IGSC) Due to Increased Reports of Allergic/Hypersensitivity Reactions
March 10, 2025 – As a precautionary measure, the following lots of Immune Globulin Intravenous (IGIV) and Immune Globulin Subcutaneous (IGSC) have been voluntarily withdrawn by the manufacturers due...
FDA Medwatch Alert: Voluntary Lot Withdrawals of Immune Globulin Intravenous (IGIV) and Immune Globulin Subcutaneous (IGSC) for Increased Reports of Allergic/Hypersensitivity Reactions
March 4, 2022 – As a precautionary measure, the following lots of Immune Globulin Intravenous (IGIV) and Immune Globulin Subcutaneous (IGSC) have been voluntarily withdrawn by the manufacturers due...
Further information
Related condition support groups
Idiopathic (Immune) Thrombocytopenic Purpura